Summary
Overview
Dr. Andrew Huberman interviews Dr. Casey Halpern, a neurosurgeon specializing in deep brain stimulation and stereotactic functional neurosurgery at Penn Medicine. The conversation explores cutting-edge treatments for neurological and psychiatric disorders, including OCD, eating disorders, and addiction. Dr. Halpern discusses how precise electrical stimulation of brain regions like the nucleus accumbens can interrupt pathological patterns of behavior, from tremors to compulsive eating. The episode delves into both invasive techniques like deep brain stimulation and emerging non-invasive approaches such as transcranial magnetic stimulation and focused ultrasound, offering hope for millions suffering from treatment-resistant conditions.
Introduction to Neurosurgery and Deep Brain Stimulation
Dr. Halpern explains the broad scope of neurosurgery, from trauma and tumor removal to his specialized focus on deep brain stimulation. He describes how neurosurgeons implant thin wires into specific brain regions to deliver electrical therapy for conditions like Parkinson's disease. This technique has revealed unexpected benefits beyond motor symptoms, including improvements in mood and compulsive behaviors, opening new therapeutic possibilities for psychiatric conditions.
- Neurosurgery encompasses the entire central and peripheral nervous system, with most neurosurgeons performing spine surgeries
- Dr. Halpern specializes exclusively in deep brain stimulation surgery and transcranial focused ultrasound
- Deep brain stimulation involves implanting a thin insulated wire into specific brain regions to deliver electrical therapy
- Stimulating areas near the target can cause temporary side effects like laughter or panic, which can provide therapeutic insights
" I'm very privileged to be able to interact with the human brain in this way. It's always with the goal of trying to provide somebody with a meaningful therapy. "
Understanding OCD: From Symptoms to Brain Circuits
Dr. Halpern provides a comprehensive overview of obsessive-compulsive disorder, describing it as a spectrum disorder involving both cortical and subcortical brain regions. He explains that OCD involves dysfunctional circuits between the prefrontal cortex and the basal ganglia, particularly the ventral striatum including the nucleus accumbens. Treatment-resistant OCD affects about 30% of patients who don't respond to SSRIs, cognitive behavioral therapy, or exposure response prevention.
- OCD involves hyperactivity in the prefrontal and orbital frontal cortex, with abnormal projections to subcortical structures
- The ventral striatum and nucleus accumbens gate reward-seeking behavior; when perturbed, they gate compulsive behavior
- SSRIs and tricyclic antidepressants are first-line medications affecting the serotonin system
- Exposure response prevention therapy, pioneered by Edna Foa at Penn, is highly effective for many patients
- Approximately 30% of OCD patients don't respond to standard treatments and continue to suffer
" Some aspect of OCD, which we often joke about, but we should consider seriously because people do suffer from this. Some aspect of it helps us. There are famous CEOs that probably have some level of OCD, surgeons and scientists alike. So perhaps if it can be controlled, it's an asset. And but if it goes awry and is uncontrollable, then it becomes obsessive compulsive disorder. "
📚 7 more sections below
Sign up to unlock the complete summary with all insights, key points, and quotes
Get this summary + all future Huberman Lab episodes in your inbox
100% Free • Unsubscribe Anytime
Sign up now and we'll send you the complete summary of this episode, plus get notified when new Huberman Lab episodes are released—delivered straight to your inbox within minutes.